EDGAR Filing Documents for 0001725160-22-000083

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001725160-22-000083

Filing Date

2022-04-28

Accepted

2022-04-28 16:16:52

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	zntl-defa14acoverpagexinte.htm	DEFA14A	18427
2		defa14a-additionalproxymat.jpg	GRAPHIC	142456
3		defa14a-additionalproxymata.jpg	GRAPHIC	54955
	Complete submission text file	0001725160-22-000083.txt		291790

Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018

Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791

Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39263 | Film No.: 22866776
SIC: 2834 Pharmaceutical Preparations